Effects of short-term atorvastatin treatment on global fibrinolytic capacity, and sL-selectin and sFas levels in hyperlipidemic patients with coronary artery disease
- 1 August 2002
- journal article
- clinical trial
- Published by Elsevier in International Journal of Cardiology
- Vol. 84 (2-3) , 227-231
- https://doi.org/10.1016/s0167-5273(02)00148-1
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Effects of statins on vascular wall: vasomotor function, inflammation, and plaque stabilityCardiovascular Research, 2000
- Simvastatin inhibits the monocyte expression of proinflammatory cytokines in patients with hypercholesterolemiaJournal of the American College of Cardiology, 2000
- The evolving role of statins in the management of atherosclerosisJournal of the American College of Cardiology, 1999
- Pravastatin therapy in hyperlipidemia: effects on thrombus formation and the systemic hemostatic profileJournal of the American College of Cardiology, 1999
- HMG-CoA reductase inhibition by atorvastatin reduces neointimal inflammation in a rabbit model of atherosclerosisJournal of the American College of Cardiology, 1998
- Influence of Pravastatin and Plasma Lipids on Clinical Events in the West of Scotland Coronary Prevention Study (WOSCOPS)Circulation, 1998
- Statins do more than just lower cholesterolThe Lancet, 1996
- Hyperlipidemia and Coronary DiseaseCirculation, 1995
- Prevention of Coronary Heart Disease with Pravastatin in Men with HypercholesterolemiaNew England Journal of Medicine, 1995
- Coronary Angiographic Changes with Lovastatin Therapy: The Monitored Atherosclerosis Regression Study (MARS)Annals of Internal Medicine, 1993